SODIUM SULFACETAMIDE AND SULFUR

SODIUM SULFACETAMIDE AND SULFUR was reported 21 times

SODIUM SULFACETAMIDE AND SULFUR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VACCINATION SITE VESICLES 1 0.0455
1 PSEUDOFOLLICULITIS 1 0.0159
2 BLADDER CYST 1 0.0062
3 LOCAL REACTION 1 0.0013
4 CHEMICAL INJURY 1 0.0012
5 FOOD REFUSAL 1 0.0011
6 INFUSION SITE BRUISING 1 0.0005
7 DEVICE INFUSION ISSUE 1 0.0004
8 EXPOSURE TO TOXIC AGENT 1 0.0003
9 SOCIAL PROBLEM 1 0.0002
10 HORDEOLUM 1 0.0002
11 PRODUCT PHYSICAL CONSISTENCY ISSUE 1 0.0002
12 CYSTIC FIBROSIS 1 0.0002
13 EXERCISE TOLERANCE DECREASED 1 0.0002
14 EXTRASYSTOLES 1 0.0001
15 IMPAIRED QUALITY OF LIFE 2 0.0001
16 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
17 CONCUSSION 1 0.0001
18 MULTIPLE ALLERGIES 1 0.0001
19 INFUSION SITE ERYTHEMA 1 0.0001
20 PRODUCT DISTRIBUTION ISSUE 1 0.0001
21 SKIN LACERATION 1 0.0001
22 DERMATITIS CONTACT 1 0.0001
23 MYDRIASIS 1 0.0001
24 QUALITY OF LIFE DECREASED 1 0.0001
25 SEASONAL ALLERGY 1 0.0001
26 SKIN HAEMORRHAGE 1 0.0001
27 CANDIDA INFECTION 1 0.0001
28 BLOOD URINE PRESENT 1 0.0001
29 SLEEP APNOEA SYNDROME 1 0.0001
30 INJECTION SITE WARMTH 1 0.0000
31 SKIN CANCER 1 0.0000
32 SKIN IRRITATION 2 0.0000
33 RESPIRATORY TRACT INFECTION 1 0.0000
34 PALLOR 1 0.0000
35 LETHARGY 2 0.0000
36 PRODUCT SUBSTITUTION ISSUE 2 0.0000
37 LIMB DISCOMFORT 1 0.0000
38 STAPHYLOCOCCAL INFECTION 1 0.0000
39 SKIN DISORDER 1 0.0000
40 INJECTION SITE PRURITUS 2 0.0000
41 INJECTION SITE SWELLING 2 0.0000
42 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
43 NEPHROLITHIASIS 1 0.0000
44 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
45 ARRHYTHMIA 1 0.0000
46 RASH ERYTHEMATOUS 1 0.0000
47 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
48 FLUID RETENTION 1 0.0000
49 PLATELET COUNT DECREASED 2 0.0000
50 OEDEMA 1 0.0000
51 URTICARIA 3 0.0000
52 ASTHMA 2 0.0000
53 EYE IRRITATION 1 0.0000
54 FEELING HOT 1 0.0000
55 BURNING SENSATION 1 0.0000
56 SLEEP DISORDER 1 0.0000
57 HALLUCINATION 1 0.0000
58 TACHYCARDIA 1 0.0000
59 NASOPHARYNGITIS 2 0.0000
60 HYPERSENSITIVITY 2 0.0000
61 CONTUSION 1 0.0000
62 SOMNOLENCE 2 0.0000
63 SINUSITIS 1 0.0000
64 ERYTHEMA 2 0.0000
65 ILLNESS 1 0.0000
66 INFLUENZA 1 0.0000
67 WEIGHT INCREASED 2 0.0000
68 OEDEMA PERIPHERAL 1 0.0000
69 LOSS OF CONSCIOUSNESS 1 0.0000
70 DRY SKIN 1 0.0000
71 PRODUCT QUALITY ISSUE 1 0.0000
72 PERIPHERAL SWELLING 1 0.0000
73 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
74 ABDOMINAL PAIN UPPER 1 0.0000
75 RASH 2 0.0000
76 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
77 COUGH 1 0.0000
78 ANXIETY 1 0.0000
79 PRODUCT DOSE OMISSION ISSUE 1 0.0000
80 PAIN 2 0.0000
81 FALL 1 0.0000
82 PYREXIA 1 0.0000
83 ASTHENIA 1 0.0000
84 PRURITUS 1 0.0000
85 MALAISE 1 0.0000
86 VOMITING 1 0.0000
87 DYSPNOEA 1 0.0000
88 DIARRHOEA 1 0.0000
89 NAUSEA 1 0.0000
90 DRUG INEFFECTIVE 1 0.0000